Mark LegareApr 125 minWhy We InvestedPortfolio Highlight - Our Investment in Voda.AICertain industries match well with certain founder profiles. A statement as equally true as it is banal. Within the vast domain ...
Matt FatesSep 21, 20224 minWhy We InvestedWhy We Invested: Dyania HealthBy Matt Fates, Partner at Innospark Ventures At any given time, there are roughly 400,000 clinical trials occurring globally. In the US,...
Matt FatesJul 7, 20223 minWhy We InvestedWhy We Invested: ODAIA IntelligenceAs skilled and advanced as the $2T pharma industry is in many regards, there are still key areas where it lags behind, and we believe...